Astera Cancer Care
Edward Licitra serves as a member of the Board of Directors for OneOncology and the Community Oncology Alliance while holding the position of Chief Executive Officer at Astera Cancer Care since April 2021. With a robust background in oncology and healthcare leadership, Edward was previously a member of the Board of Directors at MMXPS MedMetrix Professional Services and Cota, Inc., and served as Chairman of the Board at Regional Cancer Care Associates from 2012 to 2019. Edward's educational credentials include a Ph.D. in Biochemistry and Molecular Biology from the Massachusetts Institute of Technology, an M.D. from Rutgers Robert Wood Johnson Medical School, and a Bachelor's degree in Chemistry from the College of the Holy Cross.
This person is not in any teams
This person is not in any offices
Astera Cancer Care
Astera Cancer Care (ACC) is a multispecialty physician practice consisting of medical oncologists, radiation oncologists, and breast surgeons focused on the care of patients with cancer and blood disorders. ACC physicians have cared for thousands of patients in New Jersey since 1981. ACC providers currently practice at 14 distinct locations in Middlesex, Somerset, Hunterdon, Mercer, and Monmouth counties in New Jersey as well as in Bucks County, Pennsylvania. ACC offers standard and advanced therapeutics, including chemotherapy, biologic therapy, immunotherapy and radiopharmaceuticals along with a complete portfolio of radiation oncology treatment options, including proton therapy, prostate brachytherapy, and radiosurgery. The practice is one of the few private groups on the East Coast to offer patients this full array of radiation oncology treatments. Astera has a robust clinical trial platform for cancer therapy with one of the only community-based clinical trial programs in CAR-T cell therapies in the nation. The group is also a leader in value-based oncology care and alternative payment model development.